Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
- Advancing gene editing with new CRISPR/Cas9 variant
- New review confirms disproportionate impact of COVID-19 on Black, Hispanic populations
- Low-dose CT for lung cancer screening: benefit outweighs potential harm
- Chemists get peek at novel fluorescence
- Tech makes it possible to digitally communicate through human touch